Intrinsiqq
DexCom, Inc. logo

DexCom, Inc. (DXCM) Insider Trading

Last 12 months

Insiders bought $1M and sold $12.8M on the open market.

All of the selling was scheduled in advance under 10b5-1 plans.

Net open-market
−$11.8M
1 buy · 25 sales
Under a 10b5-1 plan
100%
of the value sold
Insiders who bought / sold
1 / 9
executives and directors
Last open-market buy
Nov 2025
Nov 10, 2025

Get an email when DXCM's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

  • Oct 1510b5-1 plan
    Michael Jon Brown
    EVP Chief Legal Compliance Off · sold 1,700 at $85.48
    $145k
    1.7% of stake
  • Sep 2810b5-1 plan
    Sadie Stern
    EVP Chief People & Culture Off · sold 2,565 at $86.15
    $221k
    2.0% of stake
  • Sep 14 – 1510b5-1 plan
    Nicholas Augustinos
    Director · sold 8,089 at avg $84.04
    $680k
    19% of stake
  • Sep 1510b5-1 plan
    Michael Jon Brown
    EVP Chief Legal Compliance Off · sold 1,700 at $84.04
    $143k
    1.7% of stake
  • Sep 1010b5-1 plan
    Jereme M Sylvain
    EVP, Chief Financal Officer · sold 3,638 at $83.27
    $303k
    2.4% of stake
  • Aug 2710b5-1 plan
    Sadie Stern
    EVP Chief People & Culture Off · sold 2,565 at $88.37
    $227k
    2.0% of stake
  • Aug 2010b5-1 plan
    Kevin R Sayer
    Executive Chair · sold 26,756 at avg $90.01
    $2.41M
    8.1% of stake
  • Aug 1410b5-1 plan
    Michael Jon Brown
    EVP Chief Legal Compliance Off · sold 1,700 at $91.93
    $156k
    1.6% of stake
  • Aug 1210b5-1 plan
    Bridgette P Heller
    Director · sold 1,012 at $88.29
    $89k
    3.3% of stake
  • Jul 31 – Aug 310b5-1 plan
    Mark G Foletta
    Director · sold 4,000 at avg $82.66
    $331k
    6.8% of stake
  • Jul 2010b5-1 plan
    Kevin R Sayer
    Executive Chair · sold 26,756 at $76.32
    $2.04M
    7.5% of stake
  • Jul 1510b5-1 plan
    Michael Jon Brown
    EVP Chief Legal Compliance Off · sold 1,700 at $74.42
    $127k
    1.6% of stake
  • Jul 610b5-1 plan
    Kevin R Sayer
    Executive Chair · sold 26,756 at $72.00
    $1.93M
    7.0% of stake
  • Jun 1510b5-1 plan
    Michael Jon Brown
    EVP Chief Legal Compliance Off · sold 1,700 at $75.55
    $128k
    1.6% of stake
  • Jun 1510b5-1 plan
    Mark G Foletta
    Director · sold 4,000 at avg $74.14
    $297k
    6.3% of stake
  • Jun 3 – 410b5-1 plan
    Jon Coleman
    EVP, Chief Commercial Officer · sold 9,823 at avg $73.56
    $723k
    9.3% of stake
  • May 2110b5-1 plan
    Kevin R Sayer
    Executive Chair · sold 26,759 at $72.00
    $1.93M
    6.5% of stake
  • May 1510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 1,700 at $59.91
    $102k
    1.5% of stake
  • May 1210b5-1 plan
    Bridgette P Heller
    Director · sold 1,012 at $60.01
    $61k
    3.9% of stake
  • Apr 1510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 1,700 at $63.04
    $107k
    1.5% of stake
  • Mar 1610b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 1,700 at $64.85
    $110k
    1.5% of stake
  • Feb 1210b5-1 plan
    Bridgette P Heller
    Director · sold 1,012 at $68.01
    $69k
    3.7% of stake
  • Nov 14, 202510b5-1 plan
    Richard Alexander Collins
    Director · sold 2,906 at $59.05
    $172k
    6.7% of stake
  • Nov 12, 202510b5-1 plan
    Bridgette P Heller
    Director · sold 1,012 at $58.07
    $59k
    3.6% of stake
  • Nov 10, 2025
    Jacob Steven Leach
    President & COO · bought 18,200 at avg $55.04
    $1M
    5.0% of stake
  • Nov 10, 202510b5-1 plan
    Richard Alexander Collins
    Director · sold 3,948 at $55.17
    $218k
    8.4% of stake
  • Sep 5, 202510b5-1 plan
    Kyle Malady
    Director · sold 667 at $80.86
    $54k
    2.9% of stake
  • Sep 4, 202510b5-1 plan
    Sadie Stern
    EVP, Chief HR Officer · sold 1,466 at $80.00
    $117k
    1.4% of stake
  • Sep 2, 202510b5-1 plan
    Jereme M Sylvain
    EVP, Chief Financal Officer · sold 4,824 at $74.17
    $358k
    3.9% of stake
  • Aug 15, 202510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 500 at $80.29
    $40k
    0.5% of stake
  • Aug 15, 202510b5-1 plan
    Mark G Foletta
    Director · sold 2,750 at avg $81.06
    $223k
    4.6% of stake
  • Jul 28, 202510b5-1 plan
    Sadie Stern
    EVP, Chief HR Officer · sold 1,466 at $88.99
    $130k
    1.4% of stake
  • Jul 15, 202510b5-1 plan
    Mark G Foletta
    Director · sold 2,750 at avg $85.17
    $234k
    4.4% of stake
  • Jul 15, 202510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 500 at $86.03
    $43k
    0.5% of stake
  • Jun 26, 202510b5-1 plan
    Sadie Stern
    EVP, Chief HR Officer · sold 1,466 at $85.06
    $125k
    1.3% of stake
  • Jun 16, 202510b5-1 plan
    Mark G Foletta
    Director · sold 2,750 at $83.13
    $229k
    4.2% of stake
  • Jun 16, 202510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 500 at $82.80
    $41k
    0.5% of stake
  • Jun 13, 2025 – Jun 16, 202510b5-1 plan
    Nicholas Augustinos
    Director · sold 6,290 at avg $82.34
    $518k
    14% of stake
  • May 27, 202510b5-1 plan
    Sadie Stern
    EVP, Chief HR Officer · sold 6,184 at $85.11
    $526k
    5.3% of stake
  • May 23, 202510b5-1 plan
    Michael Jon Brown
    EVP, Chief Legal Officer · sold 10,000 at $84.28
    $843k
    9.5% of stake
How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch DXCM, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Related stocks: Surgical & Medical Instruments & Apparatus

Spot a number that looks wrong? Check it in DXCM's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing DXCM

Create a free account and get 14 days of Premium: every stock and every tool.

  • Unlimited stocks
  • Stock screener
  • Portfolio tracker
  • Editable DCF
  • Compare side by side
  • Unlimited alerts

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.

SectorsPrivacyTerms© 2026 Intrinsiqq

Not financial advice. Analytical data for research only.

Intrinsiqq is a Netherlands-based company operating in Rotterdam, KvK 73238007.